Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth
The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes across drug development and manufacturing as well as supply chain and logistics.
It also analyzes the dynamics catalyzing growth, profiles organizations promising significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape. Furthermore, the research also highlights the adoption of newer business models by the game-changing companies to adapt to the changing trend of a value-based care model as opposed to the traditional volume-based model.
Key Target Audience: • Small to mid-sized pharma and biotech companies which need to benchmark their capabilities with respect to the game-changing companies
• Big pharma companies interested in gaining an understanding of the competitive landscape with respect to strategic growth levers
Research Scope: The research service covers the top 5 pharmaceutical companies in the United States (US), based on their industry position. The companies included in the study are Pfizer, Gilead, Johnson & Johnson, Merck & Co., and Amgen.
These companies are benchmarked across 5 key growth levers: • Core areas of focus
• Digital footprint
• Value chain excellence
• Strategic collaborations and partnerships, and
• Beyond the pill services and solutions
The benchmarking across these strategic growth levers would provide insights into their positioning with respect to the changing market landscape as well as measures taken by these companies to align themselves with these changing market needs. Furthermore, there are additional highlights provided on the companies being profiled.
Highlights of the company profiles include: • Company snapshot
• Performance analysis (market revenue forecast)
• Portfolio analysis
• Key marketed products and patent expiry
• SWOT analysis
• Strategic analysis of growth levers
Key Questions this Study will Answer: • What are the key therapeutic focus areas for the leading pharmaceutical companies in the US?
• What are the major growth levers affecting the growth trajectory of pharma companies in the US?
• In what ways are these growth levers impacting the company profitability?
• Which are the major game-changing companies in the US?
• What are the strategies adopted by these companies to meet the changing market needs?
• How are the companies performing across these strategic growth levers?
Our reports have been used by over 10K customers, including:
Global Optical Genome Mapping Market, By Component (Instruments v/s Consumables), By Application (Genome Assembly, SV Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Clinical Laboratories, Others), By Region, Competition Forecast...
175 pages •
By The Business Research Company
• Aug 2021
Major players in the aseptic packaging market are Reynolds Group Holdings Limited, Amcor Limited, Tetra Laval International S.A, Greatview Aseptic Packaging Co. Ltd., Tetra Pak International SA, Sig Combibloc AG, SIG Combiboc Obeikan, ELOPAK Group, Sealed Air Corporation, DS Smith Plc, and UFlex Limited. The global aseptic packaging...
The global n-hexane market reached a volume of 2.8 Million Tons in 2020. Looking forward, the analyst expects the market to exhibit stable growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries....
Free Fatty Acid Receptor 1 - Drugs In Development, 2021 Summary According to the recently published report ’Free Fatty Acid Receptor 1 - Drugs In Development, 2021’; Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 18 molecules. Out...
Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...
At present, the pharmaceutical industry is dominated by the presence of small molecule products, which represent close to 80% of the overall pipeline. Even though biologics have shown significant promise in the treatment of a wide range of disorders, in recent years, approval of novel small molecules has been...
204 pages •
By Asia Market Information & Development Company
• Jul 2021
China’s demand for Citrate has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
120 pages •
By Infiniti Research Limited
• Jul 2021
Global Chromatography Resins Market 2021-2025 The analyst has been monitoring the chromatography resins market and it is poised to grow by $ 1.22 bn during 2021-2025, progressing at a CAGR of almost 9% during the forecast period. Our report on chromatography resins market provides a holistic analysis, market size and forecast,...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.